Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,604 public trials 547 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

QUIREDEX: Revlimid (Lenalidomide) and Dexamethasone (ReDex) Treatment Versus Observation in Patients With Smoldering Multiple Myeloma With High Risk of Progression

NCT00480363

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations
  • Hospital germans Trias i Pujol Badalona, Spain
  • Hospital Clínic i Provincial de Barcelona Barcelona, Spain
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
  • Hospital del SAS de Jerez de la Frontera Jerez de la Frontera, Spain
View all 13 locations
View Trial Details
Completed

Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma

NCT00723359

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Mount Sinai Medical Center New York, United States
View Trial Details
Completed

Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia

NCT00005579

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +24 more
Locations
  • Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States
  • Vermont Cancer Center Burlington, Vermont, United States
View Trial Details

Related conditions